Literature DB >> 14764075

Lack of detrimental effects of nitric oxide inhibition in bile duct-ligated rats with hepatic encephalopathy.

C-Y Chan1, S-W Huang, T-F Wang, R-H Lu, F-Y Lee, F-Y Chang, C-J Chu, Y-C Chen, C-C Chan, H-C Huang, S-D Lee.   

Abstract

BACKGROUND: The pathogenetic mechanisms of hepatic encephalopathy (HE) are not fully understood. Vasodilatation induced by nitric oxide (NO) may be involved in the development of HE. There is no comprehensive data concerning the effects of NO inhibition on HE in chronic liver disease.
METHODS: Male Sprague-Dawley rats weighing 240-270 g at the time of surgery were selected for experiments. Secondary biliary cirrhosis was induced by bile duct ligation (BDL). Counts of movements were compared between BDL rats and rats receiving a sham operation. In another series of experiments, BDL rats received either Nomega-nitro-L-arginine methyl ester (L-NAME, 25 mg kg-1 day-1 in tap water) or tap water (control) from the 36th to 42nd days after BDL. Besides motor activities, plasma levels of tumour necrosis factor (TNF)-alpha and nitrate/nitrite, liver biochemistry tests and haemodynamics were determined after treatment.
RESULTS: Compared with the sham-operated rats, the total, ambulatory and vertical movements were significantly decreased in the BDL rats (P </= 0.001). The L-NAME group had a significantly higher mean arterial pressure than that of the control group (119.0 +/- 2.5 mmHg vs. 97.3 +/- 2.8 mmHg, P = 0.002). However, the counts of motor activities, plasma levels of TNF-alpha and nitrate/nitrite, and serum biochemistry tests were not significantly different between the L-NAME and control groups.
CONCLUSIONS: Bile duct ligation may induce HE evidenced by a decrease in motor activities. However, chronic L-NAME administration did not have significantly detrimental or therapeutic effects on the severity of encephalopathy in BDL rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764075     DOI: 10.1111/j.1365-2362.2004.01295.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy.

Authors:  Saurabh Dhanda; Aditya Sunkaria; Avishek Halder; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2017-11-14       Impact factor: 3.584

2.  Bile Acids in Hepatic Encephalopathy.

Authors:  Sharon DeMorrow
Journal:  J Clin Exp Hepatol       Date:  2018-05-04

Review 3.  Animal models in the study of episodic hepatic encephalopathy in cirrhosis.

Authors:  Rodrigo Jover; Enriquede Madaria; Vicente Felipo; Regina Rodrigo; Asunción Candela; Antonio Compañ
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

4.  Impairment of the organization of locomotor and exploratory behaviors in bile duct-ligated rats.

Authors:  Renata Leke; Diogo L de Oliveira; Ben Hur M Mussulini; Mery S Pereira; Vanessa Kazlauckas; Guilherme Mazzini; Carolina R Hartmann; Themis R Silveira; Mette Simonsen; Lasse K Bak; Helle S Waagepetersen; Susanne Keiding; Arne Schousboe; Luis V Portela
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

5.  Brain cholinergic impairment in liver failure.

Authors:  María-Salud García-Ayllón; Omar Cauli; María-Ximena Silveyra; Regina Rodrigo; Asunción Candela; Antonio Compañ; Rodrigo Jover; Miguel Pérez-Mateo; Salvador Martínez; Vicente Felipo; Javier Sáez-Valero
Journal:  Brain       Date:  2008-09-04       Impact factor: 13.501

6.  Pharmacological manipulation of cyclic GMP levels in brain restores learning ability in animal models of hepatic encephalopathy: therapeutic implications.

Authors:  Regina Rodrigo; Pilar Monfort; Omar Cauli; Slaven Erceg; Vicente Felipo
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.